ASCA- IgG:
Why Anti-SacromycesCerevisiaeIgG Antibody test?
CLINICAL INFORMATION :
Anti-SacromycesCerevisiaeIgG Antibody is used in inflammatory bowel diseases, to help distinguish Crohn’s disease from ulcerative colitis. As there is no single test for the diagnosis of Crohn’s disease, apart from clinical signs and symptoms diagnosis is arrived by blood tests (including ASCA Antibody test), stool tests, colonoscopy, sigmoidoscopy or tissue biopsies. In the majority antibodies to Sacromycescerevisiae are found in approximately in 75% of patients with Crohn’s disease. Hence high antibody titers increase the likelihood of this disease. ASCA IgG antibody ELISA-test is based on the antibodies directed against mannan present in the cell membrane of S.cerevisiae.
General instructions:
Sample Requirement: Specimen - Blood sample collected from the vein. Test Preparation: None.
NOTE - Sample for specimen collections may vary based on the patient’s condition/cases according to the patient’s presenting complaints/signs or symptoms:
SPECIMEN REQUIREMENT (Special or Rare Cases) - As instructed and guided by Physician / Clinician / Pathologist / as per Laboratory’s requirements, according to procedures and protocols.
This Multi-Specialty Clinical Referral Laboratory RTDIAGNOSTICS provides precise and accurate tests with an extensive range of testing services to the medical centers to help in the diagnosis and identification of pathology in the test specimens for infectious diseases and also to evaluate the function of organ systems of the patient. It prevents further complications and helps to stabilize and restore health to near normalcy at the earliest without delay.
